top of page

tir. 25. mai


Internal meeting

Using RWD for drug approval

This is an internal CONNECT meeting, hosted by Working Group 4.

This is a closed meeting.
See other events
Using RWD for drug approval
Using RWD for drug approval

Time & Location

25. mai 2021, 15:30 – 16:45

Internal meeting

About the event

Topics and speakers:

RWD in regulatory processes, hurdles and possibilities from the Regulatory Authority perspective

Anja Schiel, Special Adviser and Lead Methodologist in Regulatory and Pharmacoeconomic Statistics, Norwegian Medicines Agency

RWD: The perspective from a Pharmaceutical company

Leah Burns, Director, WW HEOR, RWE Strategy, Bristol Myers Squibb, USA

Please note: This is a CONNECT internal, closed meeting. CONNECT Partners receive a personal calendar invite / email invitation. If you are a CONNECT Partners and haven't received an invite, please contact Jutta Heix (

Share this event

bottom of page